New radiation technique tested in fight against relapsed blood cancers
NCT ID NCT02333162
Summary
This study is testing a new, more targeted form of radiation to the bone marrow (called IMTMI) given with two chemotherapy drugs before a second stem cell transplant. The goal is to see if this combination is safe and can better prepare patients with advanced blood cancers (like leukemia) that have come back after treatment. Researchers want to find the best dose of the new radiation to help control the cancer and allow the donor's stem cells to grow.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ADULT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.